+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

North America Bariatric Surgery Devices Market Size, Share & Industry Trends Analysis Report by Devices Type, Procedure, Country and Growth Forecast, 2022-2028

  • PDF Icon

    Report

  • 85 Pages
  • September 2022
  • Region: North America
  • Marqual IT Solutions Pvt. Ltd (KBV Research)
  • ID: 5673567
The North America Bariatric Surgery Devices Market would witness market growth of 4.7% CAGR during the forecast period (2022-2028).

Making alterations to the digestive tract is a component of bariatric surgery, which includes gastric bypass as well as other weight-loss procedures. When exercise and diet have failed or when patients are experiencing major health issues as a result of high weight, bariatric surgery is performed. The ability to eat more is restricted by several procedures. Other approaches work by making it challenging for the body to absorb nutrients. Some techniques perform both. Even though there are numerous advantages to bariatric surgery, it is a substantial procedure with significant risks and negative effects. To assist assure the long-term success of bariatric surgery, patients must also permanently adjust their diet and engage in regular exercise.

The body's capacity to reach a healthy weight is enhanced by these methods. Each surgical procedure has unique benefits and potential downsides. In order to choose the best operation for the patient, the bariatric surgeon would examine the medical history and consult with the patient. Obesity is linked to a lower quality of life, numerous physical limits, a sense of exhaustion, and physical pain. Many people who have had weight loss surgery say their quality of life has improved as a result of the procedure.

Obesity is another emerging issue in regional countries, which is needed to be addressed as soon as possible. According to the Centers for Disease Control and Prevention, in the United States, the prevalence of obesity was 41.9% from 2017 to March 2020. (2021 NHANES). The prevalence of obesity in the US rose from 30.5% to 41.9% from 1999 to 2000 to March 2020. The prevalence of extreme obesity rose from 4.7% to 9.2% throughout the same period. (2021 NHANES).

Heart disease, type 2 diabetes, stroke, and a few cancer types are all diseases linked to obesity. These are some of the main reasons why people die too young and avoidably. Owing to the high prevalence of obesity along with the increasing efforts of the government to reduce it, the demand and adoption of bariatric surgery are estimated to rise significantly in the region. This factor is boosting the growth of the regional market.

The US market dominated the North America Bariatric Surgery Devices Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $640.8 million by 2028. The Canada market is exhibiting a CAGR of 7.1% during (2022-2028). Additionally, The Mexico market would experience a CAGR of 6.2% during (2022-2028).

Based on Devices Type, the market is segmented into Minimally Invasive Surgical Devices and Noninvasive Surgical Devices. Based on Minimally Invasive Surgical Devices Type, the market is segmented into Accessories, Suturing Devices, Stapling Devices and Energy/Vessel-sealing Devices. Based on Procedure, the market is segmented into Sleeve Gastrectomy, Noninvasive Bariatric Surgery, Adjustable Gastric Banding, Gastric Bypass, Revision Bariatric Surgery, Mini-gastric Bypass and Biliopancreatic Diversion with Duodenal Switch (BPD/DS). Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Johnson & Johnson, ReShape Lifesciences, Inc., Apollo Endosurgery, Inc., Medtronic PLC, Olympus Corporation, Intuitive Surgical, Inc., B. Braun Melsungen AG, Spatz FGIA, Inc., Cook Medical, Inc. (Cook Group), and Richard Wolf GmbH.

Scope of the Study

Market Segments Covered in the Report:

By Devices Type

  • Minimally Invasive Surgical Devices
  • Accessories
  • Suturing Devices
  • Stapling Devices
  • Energy/Vessel-sealing Devices
  • Noninvasive Surgical Devices

By Procedure

  • Sleeve Gastrectomy
  • Noninvasive Bariatric Surgery
  • Adjustable Gastric Banding
  • Gastric Bypass
  • Revision Bariatric Surgery
  • Mini-gastric Bypass
  • Biliopancreatic Diversion with Duodenal Switch (BPD/DS)

By Country

  • US
  • Canada
  • Mexico
  • Rest of North America

Key Market Players

List of Companies Profiled in the Report:

  • Johnson & Johnson
  • ReShape Lifesciences, Inc.
  • Apollo Endosurgery, Inc.
  • Medtronic PLC
  • Olympus Corporation
  • Intuitive Surgical, Inc.
  • B. Braun Melsungen AG
  • Spatz FGIA, Inc.
  • Cook Medical, Inc. (Cook Group)
  • Richard Wolf GmbH

Unique Offerings from the Publisher

  • Exhaustive coverage
  • The highest number of Market tables and figures
  • Subscription-based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free

Table of Contents

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Bariatric Surgery Market, by Devices Type
1.4.2 North America Bariatric Surgery Market, by Procedure
1.4.3 North America Bariatric Surgery Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market composition and scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Strategies Deployed in Bariatric Surgery Devices Market
Chapter 4. North America Bariatric Surgery Devices Market by Devices Type
4.1 North America Minimally Invasive Surgical Devices Market by Country
4.2 North America Bariatric Surgery Devices Market by Minimally Invasive Surgical Devices Type
4.2.1 North America Accessories Market by Country
4.2.2 North America Suturing Devices Market by Country
4.2.3 North America Stapling Devices Market by Country
4.2.4 North America Energy/Vessel-sealing Devices Market by Country
4.3 North America Noninvasive Surgical Devices Market by Country
Chapter 5. North America Bariatric Surgery Devices Market by Procedure
5.1 North America Sleeve Gastrectomy Market by Country
5.2 North America Noninvasive Bariatric Surgery Market by Country
5.3 North America Adjustable Gastric Banding Market by Country
5.4 North America Gastric Bypass Market by Country
5.5 North America Revision Bariatric Surgery Market by Country
5.6 North America Mini-gastric Bypass Market by Country
5.7 North America Biliopancreatic Diversion with Duodenal Switch (BPD/DS) Market by Country
Chapter 6. North America Bariatric Surgery Devices Market by Country
6.1 US Bariatric Surgery Devices Market
6.1.1 US Bariatric Surgery Devices Market by Devices Type
6.1.1.1 US Bariatric Surgery Devices Market by Minimally Invasive Surgical Devices Type
6.1.2 US Bariatric Surgery Devices Market by Procedure
6.2 Canada Bariatric Surgery Devices Market
6.2.1 Canada Bariatric Surgery Devices Market by Devices Type
6.2.1.1 Canada Bariatric Surgery Devices Market by Minimally Invasive Surgical Devices Type
6.2.2 Canada Bariatric Surgery Devices Market by Procedure
6.3 Mexico Bariatric Surgery Devices Market
6.3.1 Mexico Bariatric Surgery Devices Market by Devices Type
6.3.1.1 Mexico Bariatric Surgery Devices Market by Minimally Invasive Surgical Devices Type
6.3.2 Mexico Bariatric Surgery Devices Market by Procedure
6.4 Rest of North America Bariatric Surgery Devices Market
6.4.1 Rest of North America Bariatric Surgery Devices Market by Devices Type
6.4.1.1 Rest of North America Bariatric Surgery Devices Market by Minimally Invasive Surgical Devices Type
6.4.2 Rest of North America Bariatric Surgery Devices Market by Procedure
Chapter 7. Company Profiles
7.1 Johnson & Johnson
7.1.1 Company Overview
7.1.2 Financial Analysis
7.1.3 Segmental &Regional Analysis
7.1.4 Research & Development Expenses
7.1.5 Recent strategies and developments:
7.1.5.1 Partnerships, Collaborations, and Agreements:
7.1.5.2 Product Launches and Product Expansions:
7.2 ReShape Lifesciences, Inc.
7.2.1 Company Overview
7.2.2 Financial Analysis
7.2.3 Regional Analysis
7.2.4 Research & Development Expenses
7.2.5 Recent strategies and developments:
7.2.5.1 Partnerships, Collaborations, and Agreements:
7.2.5.2 Acquisition and Mergers:
7.2.5.3 Approvals and Trials:
7.3 Apollo Endosurgery, Inc.
7.3.1 Company Overview
7.3.2 Financial Analysis
7.3.3 Regional Analysis
7.3.4 Research & Development Expenses
7.3.5 Recent strategies and developments:
7.3.5.1 Approvals and Trials:
7.4 Medtronic PLC
7.4.1 Company overview
7.4.2 Financial Analysis
7.4.3 Segmental and Regional Analysis
7.4.4 Research & Development Expenses
7.4.5 Recent strategies and developments:
7.4.5.1 Acquisition and Mergers:
7.4.6 SWOT Analysis
7.5 Olympus Corporation
7.5.1 Company Overview
7.5.2 Financial Analysis
7.5.3 Segmental and Regional Analysis
7.5.4 Research & Development Expense
7.5.5 Recent strategies and developments:
7.5.5.1 Product Launches and Product Expansions:
7.6 Intuitive Surgical, Inc.
7.6.1 Company Overview
7.6.2 Financial Analysis
7.6.3 Regional Analysis
7.6.4 Research & Development Expense
7.6.5 Recent strategies and developments:
7.6.5.1 Product Launches and Product Expansions:
7.7 B. Braun Melsungen AG
7.7.1 Company Overview
7.7.2 Financial Analysis
7.7.3 Segmental and Regional Analysis
7.7.4 Research & Development Expenses
7.8 Spatz FGIA, Inc.
7.8.1 Company Overview
7.8.2 Recent strategies and developments:
7.8.2.1 Approvals and Trials:
7.9 Cook Medical, Inc. (Cook Group)
7.9.1 Company Overview
7.10. Richard Wolf GmbH
7.10.1 Company Overview

Companies Mentioned

  • Johnson & Johnson
  • ReShape Lifesciences, Inc.
  • Apollo Endosurgery, Inc.
  • Medtronic PLC
  • Olympus Corporation
  • Intuitive Surgical, Inc.
  • B. Braun Melsungen AG
  • Spatz FGIA, Inc.
  • Cook Medical, Inc. (Cook Group)
  • Richard Wolf GmbH

Methodology

Loading
LOADING...